Matthews Michael, Klein Erin, Hulst Zachary, Patel Neathie, Weil Lowell, Sorensen Matthew, Fleischer Adam
Weil Foot and Ankle Institute, Mount Prospect, IL, USA.
Foot Ankle Orthop. 2021 Oct 28;6(4):24730114211050568. doi: 10.1177/24730114211050568. eCollection 2021 Oct.
Treatment of chronic refractory heel pain has evolved to consider calcaneal structural fatigue as a component of the symptom profile. While concomitant calcium phosphate injection has become a method of addressing the accompanying calcaneal bone marrow edema (BME) frequently seen in this population, there is no literature supporting its use compared to traditional fasciotomy.
Consecutive patients with symptoms of refractory infracalcaneal heel pain and calcaneal BME were treated in our practice by either surgical fasciotomy (n = 33) or fasciotomy plus calcium phosphate injection (n = 31) between 2014 and 2019. Outcomes were retrospectively assessed via Foot and Ankle Outcome Scores (FAOS), return to activity, and complication rate.
Sixty-four patients (64 feet) were included with a mean age of 50.3 ± 12.9 years and mean follow-up of 23.2 ± 22.3 months. No differences were observed between groups preoperatively. Significant improvements in 4 of 5 FAOS subscales were observed postoperatively in both groups ( < .05 for all, paired test). However, patients undergoing concomitant calcium phosphate injection reported significantly better scores for both activities of daily living (ADL; mean difference +10.2; 95% confidence interval [CI] 0.07-20.2) and foot-specific QOL (mean difference +21.9, 95% CI 7.0-36.6) at final follow-up compared with those undergoing plantar fasciotomy alone. All patients returned to their desired level of activity, and the frequency of complications did not differ between groups ( > .05, Fisher exact test).
In patients presenting with recalcitrant infracalcaneal heel pain accompanied by calcaneal BME, calcium phosphate injection into the calcaneus, when combined with plantar fasciotomy, was safe and more effective than traditional plantar fasciotomy alone.
Level III, retrospective comparative study.
慢性难治性足跟痛的治疗已逐渐将跟骨结构疲劳视为症状表现的一个组成部分。虽然磷酸钙注射已成为治疗该人群中常见的跟骨骨髓水肿(BME)的一种方法,但与传统的筋膜切开术相比,尚无文献支持其使用。
2014年至2019年期间,我们对连续出现难治性跟骨下足跟痛和跟骨BME症状的患者采用手术筋膜切开术(n = 33)或筋膜切开术加磷酸钙注射(n = 31)进行治疗。通过足踝结果评分(FAOS)、恢复活动情况和并发症发生率对结果进行回顾性评估。
纳入64例患者(64只足),平均年龄50.3±12.9岁,平均随访23.2±22.3个月。术前两组间未观察到差异。两组术后FAOS的5个亚量表中有4个均有显著改善(所有P <.05,配对t检验)。然而,与单纯接受足底筋膜切开术的患者相比,接受磷酸钙注射的患者在最终随访时,日常生活活动(ADL)(平均差异+10.2;95%置信区间[CI] 0.07 - 20.2)和足部特定生活质量(平均差异+21.9,95% CI 7.0 - 36.6)方面的评分明显更高。所有患者均恢复到期望的活动水平,两组间并发症发生率无差异(P >.05,Fisher精确检验)。
对于伴有跟骨BME的顽固性跟骨下足跟痛患者,跟骨内注射磷酸钙联合足底筋膜切开术比单纯传统足底筋膜切开术更安全、更有效。
III级,回顾性比较研究。